id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-0588-0013,FDA,FDA-2022-D-0588,"Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements Guidance for Industry; Final Guidance",Other,Guidance,2023-10-18T04:00:00Z,2023,10,2023-10-18T04:00:00Z,,2025-11-06T10:00:05Z,,1,0,0900006486106c94
FDA-2022-D-0588-0012,FDA,FDA-2022-D-0588,"Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements; Guidance for Industry; Availability.",Rule,Final Rule,2023-10-18T04:00:00Z,2023,10,2023-10-18T04:00:00Z,,2023-10-19T13:45:19Z,2023-22957,0,0,090000648610438b
FDA-2022-D-0588-0010,FDA,FDA-2022-D-0588,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice for Blood and Blood Components and Reducing the Risk of Transfusion-Transmitted Infections,Notice,30 Day Proposed Information Collection,2023-08-24T04:00:00Z,2023,8,2023-08-24T04:00:00Z,2023-09-26T03:59:59Z,2023-09-26T01:01:03Z,2023-18245,0,0,0900006485ee0a06
FDA-2022-D-0588-0002,FDA,FDA-2022-D-0588,"Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements- Draft Guidance for Industry",Other,Guidance,2022-05-24T04:00:00Z,2022,5,2022-05-24T04:00:00Z,,2023-10-18T15:52:53Z,,0,0,09000064850def70
FDA-2022-D-0588-0003,FDA,FDA-2022-D-0588,Reference 1 Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency,Supporting & Related Material,Background Material,2022-05-24T04:00:00Z,2022,5,,,2022-05-24T15:55:26Z,,0,0,09000064850df06b
FDA-2022-D-0588-0001,FDA,FDA-2022-D-0588,"Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements; Draft Guidance for
Industry; Availability",Proposed Rule,Advance Notice of Proposed Rulemaking (ANPRM),2022-05-24T04:00:00Z,2022,5,2022-05-24T04:00:00Z,2022-07-26T03:59:59Z,2023-10-18T18:54:08Z,2022-11120,0,0,09000064850dbdae